Eli Lilly’s (NYSE: LLY) latest acquisition has electrified the biotech world—and sent a clear message that gene editing is no ...

Shares in US healthcare conglomerate Johnson & Johnson rose by 6% during Wednesday morning’s trading after the presentation ...

UK pharma major GSK is seeking US approval for Blenrep (belantamab mafodotin) in two multiple myeloma indications.

Canada and USA-based oncology biotech Repare Therapeutics has entered into an exclusive worldwide licensing agreement with ...

Bharatt Chowrira has stepped down from his role as chief executive (CEO) and board member at US biopharma PureTech Health.

The UK government’s new life sciences plan has been met with skepticism by the pharmaceutical industry, which says the ...

The Division of Hepatology and Nutrition of the US Food and Drug Administration (FDA) has lifted the partial clinical hold on ...

US pharma major AstraZeneca today released high-level results from the Cardiac Amyloid Reaching for Extended Survival (CARES) ...

The US regulator has launched a new national initiative to help Medicaid programs fund gene therapies for sickle cell disease ...

On Tuesday, the day new global data reveal that childhood vaccine coverage has stalled and deadly disease outbreaks are ...

The US Food and Drug Administration approved, the first rapid-acting interchangeable biosimilar product, Kirsty (insulin ...

Sino Biopharmaceutical (HKEX: 1177) is acquiring the remaining stake in Chinese biotech LaNova Medicines, setting the stage ...